BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT – $BIOV.CN
BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT – $BIOV.CN
Read More
BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT – $BIOV.CN
BIOVAXYS ANNOUNCES CLOSING OF FIFTH TRANCHE OF PRIVATE PLACEMENT – $BIOV.CN
Justera Health Announces Debt Settlement Transaction – $SCRSF.US $VTAL.CN
Justera Health Announces Debt Settlement Transaction – $SCRSF.US $VTAL.CN
Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) – $MDNA.TO
Medicenna to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) – $MDNA.TO
Extendicare Announces Timing of 2024 Third Quarter Results and Conference Call – $EXE.TO
Extendicare Announces Timing of 2024 Third Quarter Results and Conference Call – $EXE.TO
Cytophage CEO to Discuss Reshaping Healthcare Through Phage Therapies During 2024 Canada SynBio Conference – $CYTO.V
Cytophage CEO to Discuss Reshaping Healthcare Through Phage Therapies During 2024 Canada SynBio Conference – $CYTO.V
Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program – $AWKN.CN $AWKNF.US
Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program – $AWKN.CN $AWKNF.US
MedMira Announces the appointment of Vice President of Commercial Operations – $MIR.V
MedMira Announces the appointment of Vice President of Commercial Operations – $MIR.V
Alpha Cognition Announces Change of Officer – $ACOG.CN $ACOGF.US
Alpha Cognition Announces Change of Officer – $ACOG.CN $ACOGF.US
DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel) – $DHT-U.TO $DHT-UN.TO
DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel) – $DHT-U.TO $DHT-UN.TO